Recent Publications
Publications by the Faculty of the Penn TTURC
To view available abstracts, click on highlighted presentation titles
2007
Berrettini WH, Wileyto, EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biological Psychiatry, 2007 Jan 1;61(1):111-8.
David SP, Strong DR, Munafo MR, Brown RA, Loyd-Richardson EE, Wileyto EP, Evins AE, Shields PG, Lerman C, Niauri R. Bupropion efficacy for smoking cessation is influenced by the DRD2 TaqlA polymorphism: Analysis of pooled data from two clinical trials. Nicotine and Tobacco Research, in press
Davis JA, Gould TJ. β2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl). 2007 Feb, 190(3) :343-353.
Davis JA, Gould TJ. Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning, Neuropsychopharmacology, in press.
Gould, T.J. Nicotine and hippocampus-dependent learning: Implications for addiction. Molecular Neurobiology, in press.
Hutchison KE, Allen D, Haughey H, Jepson C, Lerman C, Benowitz N, Stitzel J, Bryan A, Filbey F. CHRNA4 and tobacco dependence: From gene regulation to treatment outcome. Archives of General Psychiatry, in press.
Lee AM., Jepson C., Hoffmann E., Epstein L., Hawk L., Lerman C., Tyndale R. CYP2A6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biological Psychology, in press.
Lerman, C., Schnoll, R.A., & Munafò, M. Genetics and smoking cessation: Improving outcomes in smokers at risk. American Journal of Preventive Medicine, in press.
Newberg A, Lerman C, Wintering N, Ploessl K, Mozley PD. Dopamine transporter binding in smokers and non-smokers. Clinical Nuclear Medicine, in press.
Metzger KL, Maxwell CR, Liang Y, Siegel SJ. Effects of nicotine vary across two auditory evoked potentials in the mouse. Biological Psychiatry, 2007 Feb; 190(2):201-211.
Phillips J, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine and Tobacco Research, in press.
Phillips JM, Ehrlichman RS, Siegel SJ. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event related potential and evoked gamma. Neuroscience, 2007 Feb 23; 144(4):1314-1323.
Park E, Kleimann S, Pelan J, Shields AE. Anticipating clinical integration of genetically-tailored tobacco dependence treatment: Perspectives of primary care physicians. Nicotine and Tobacco Research, in press.
Ray R., Jepson C., Wileyto P., Dahl J., Patterson F., Rukstalis M., Pinto A., Berrettini W., Lerman C. Genetic variation in mu opioid receptor interacting protein and smoking cessation in a nicotine replacement therapy trial. Nicotine and Tobacco Research, in press.
Ray R, Schnoll RA, Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. CNS Drugs, in press.
Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. Journal of Women’s Health, in press.
Strasser AA, Malaiyandi V, Hoffmann E, Tyndale R, Lerman C. An association of CYP2A6 genotype and smoking topography. Cancer Epidemiology, Biomarkers and Prevention, in press.
Strasser AA, Lerman C, Sanborn PM, Pickworth W, Feldman E. New lower nicotine cigarettes produce compensatory smoking and increased carbon monoxide exposure. Drug and Alcohol Dependence, 2007 Jan 12;86(2-3):294-300.
2006
Audrain-McGovern JA, Rodriguez D, Patel V, Faith M, Rodgers K, Cuevas J. How do psychological factors influence adolescent smoking progression? The evidence for indirect effects through tobacco advertising receptivity. Pediatrics, 2006 Apr;117(4):1216-1225.
Audrain-McGovern J, Rodriguez D, Tercyak K, Neuner G, & Moss H. The impact of self-control indices on peer smoking and adolescent smoking progression. Journal of Pediatric Psychology, 2006; 31(2):139-151.
Audrain-McGovern J, Rodriguez D, Wileyto EP, Schmitz KH, Shields PG. Effect of team sport participation on genetic predisposition to adolescent smoking progression. Archives of General Psychiatry, 2006 Apr; 63(4):433-441.
Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini W, Lerman C. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics Journal, 2006; 6(3):194-199.
Davis JA, Gould TJ. The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl), 2006 Mar;184(3-4):345-352.
Davis JA, Porter J, Gould TJ. Nicotine enhances both foreground and background contextual fear conditioning. Neuroscience Letters, 2006 Feb 20; 394(3):202-205.
Franken FH, Pickworth WB, Epstein DH, Moolchan ET. Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiology Biomarkers and Prevention, 2006; 15:154-157.
Hu J, Redden DT, Berrettini WH, Shields PG, Restine SL, Pinto A, Lerman C, Allison DB. No evidence for a major role of polymorphisms during bupropion treatment.
Obesity, 2006 Nov;14 (11):1863-1867.
Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. The role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials. Neuropsychopharmacology, 2006; 31(1):231-242.
Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. Nicotine metabolite ratio predicts the efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology & Therapeutics, 2006; 79(6):600-608.
Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry, 2006; 11(4):400-409.
Munafo MR, Johnstone EC, Wileyto EP, Shields PG, Lerman C. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy Randomized Trial. Cancer Epidemiology Biomarkers and Prevention, 2006 Feb; 15(2): 398-400.
Munafo MR, Lerman C. Can pharmacogenetics help smokers quit?
Pharmacogenomics. 2006 Dec;7(8):1137-1140.
Perkins, K.A., Doyle, T.D., Ciccocioppo, M., Conklin, C., Sayette, M., & Caggiula, A. Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology, 2006; 184: 600-607.
Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl), 2006 Mar; 184(3-4):628-636.
Ray R, Jepson C, Patterson F, Strasser AA, Rukstalis M, Perkins K, Lynch KG, O’Malley S, Berrettini WH, Lerman C. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine in female smokers. Psychopharmacology, 2006; 188:355-363.
Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion on Emerging Drugs, 2006; 11(3):429-444.
Schnoll, RA, Rukstalis, M, Wileyto, P, & Shields, A. Practice of smoking cessation treatment by primary care physicians: an update and renewed call for physician training. American Journal of Preventive Medicine, 2006; 31(3):233-239.
Shadel WG, Lerman C, Cappella J, Strasser A, Pinto A, Hornik R. Evaluating smokers’ reactions to advertising for new lower nicotine Quest cigarettes. Psychology of Addictive Behaviors, 2006 Mar; 20(1):80-84.
Strasser AA, Ashare RL, Koslowski LT, Pickworth WB. The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacology Biochemistry and Behavior, 2006; 82(2):320-329.
Strasser AA, O'Connor RJ, Mooney ME, Wileyto EP. Digital image analysis of cigarette filter stains as an indicator of compensatory smoking. Cancer Epidemiology Biomarkers and Prevention, 2006 Dec;15(12):2565-9.
Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiology Biomarkers and Prevention, 2006 Jan; 15(1):12-18.
2005
Berrettini WH, Lerman C. Pharmacotherapy and pharmacogenetics of nicotine dependence. American Journal of Psychiatry, 2005; 162(8):1441-1451.
Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C. Reduced nicotine reward in obesity: Cross comparison in human and mouse. Psychopharmacology, 2005; 180(2):306-315.
Cappella JN, Lerman C, Romantan A, Baruh L. News about genetics and smoking: Priming, family smoking history, and news story credibility effects on inferring genetic susceptibility to tobacco addiction. Communication Research, 2005; 32(4):478-502.
Carson N, Rodriguez D, & Audrain-McGovern J. Investigation of mechanisms linking media exposure to smoking in high school students. Preventive Medicine, 2005; 41(2):511-520.
Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetetics and Genomics, 2005; 15(6):393-398.
Davis JA, James JR, Siegel SJ, Gould TJ. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. The Journal of Neuroscience, 2005; 25(38):8708-8713.
Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF. Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control, 2005; 14(6):422-424.
Furberg H, Sullivan PF, Maes H, Prescott CA, Lerman C, Bulik C, Kendler KS. The types of regular cigarette smokers: a latent class analysis. Nicotine and Tobacco Research, 2005; 7(3):351-360.
Gould TJ, Rukstalis M, Lewis MC. Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 Mice. Neuroscience Letters, 2005; 377(2):85-90.
Lerman C, Patterson F, Berrettini W. Treating tobacco dependence: State of the science and new directions. Journal of Clinical Oncology, 2005; 23(2):311-323.
Munafo MR, Lerman C, Niaura R, Shields AE, Swan GE. Smoking cessation treatment: pharmacogenetic assessment. Current Opinion in Molecular Therapeutics., 2005; 7(3):202-208.
Munafo MR, Shields AE, Berrettini WH, Patterson F, Lerman C. Pharmacogenetics and nicotine addiction. Pharmacogenomics, 2005; 6(3):211-223.
Munafo MR, Wileyto EP, Flint J. Response to Manly: Statistical stringency in tests of genetic association - implications of sample size and study design. Trends in Genetics, 2005; 21(5):269-271.
Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB, Lerman C. Catechol-O-Methyl-Transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiology Biomarkers and Prevention, 2005; 14(6):1-6.
Roberts KH, Munafo MR, Rodriguez D, Drury M, Murphy MFG, Neale R, Nettle D. Longitudinal analysis of prenatal nicotine exposure on offspring’s subsequent smoking behaviour. Nicotine and Tobacco Research, 2005 Oct; 7(5):801-808.
Rodriguez D & Audrain-McGovern J. Physical activity, global physical self-concept and adolescent smoking. Annals of Behavioral Medicine, 2005; 30(3):251-259.
Rodriguez D, Moss H & Audrain-McGovern J. Developmental heterogeneity in adolescent depressive symptoms: Associations with smoking behavior. Psychosomatic Medicine, 2005; 67(2):200-210.
Rukstalis M, Jepson C, Patterson F, Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment, 2005; 28(4):297-304.
Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology, 2005; 180(1):41-48.
Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. Barriers to translating emerging genetic research on smoking into clinical practice: Perspectives of primary care physicians. Journal of General Internal Medicine, 2005; 20(2):131-138.
Shields AE, Fortun M, Hammonds E, King PA, Lerman C, Rapp R, Sullivan PF. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. American Psychologist, 2005; 60(1):77-103.
Siegel SJ, Maxwell CR, Majumdar S, Treif D, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience, 2005; 133:729-738.
Strasser AA, Kaufmann V, Jepson C, Perkins KA, Pickworth WB, Wileyto EP, Rukstalis M, Audrain-McGovern J, Lerman C. Effects of different nicotine replacement therapies on post-cessation psychological responses. Addictive Behaviors, 2005; 30(1):9-17.
Walters C, Cleck JN, Kuo YC, Blendy J. Mu opiate receptor and CREB activation are required for nicotine reward. Neuron, 2005; 46(6):933-943.
Wileyto EP, Patterson F, Niaura R, Epstein L, Brown R, Audrain-McGovern J, Hawk L, Lerman C. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial utilizing bupropion. Nicotine and Tobacco Research, 2005; 7(2):257-268.
2004
Audrain-McGovern J, Rodriguez D, Cuevas J, Rodgers K, & Patterson F. Identifying and characterizing adolescent smoking trajectories. Cancer Epidemiology Biomarkers & Prevention, 2004; 13(12):2003-2034.
Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, & Shields P. Interacting effects of genetic predisposition and depression on adolescent smoking progression. American Journal of Psychiatry, 2004; 161(7): 1224-1230.
Audrain-McGovern J, Rodriguez D, Tercyak KP, Epstein L, Goldman P, Wileyto EP. Applying a behavioral framework to understanding adolescent smoking. Psychology of Addictive Behaviors, 2004; 18(1):64-73.
Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein L, Lerman C. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine and Tobacco Research, 2004; 6(1): 27-37.
Epstein LH, Wright, Paluch RA, Leddy JJ, Hawk L, Jaroni J, Saad FG, Crystal-Mansour S, Lerman C. Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiology Behavior, 2004 May; 81(3):511-517.
Epstein L, Wright S, Paluch R, Leddy J, Lerman C. The relationship between food reinforcement and dopamine genotypes on food intake in smokers. American Journal of Clinical Nutrition, 2004; 80(1)82-88.
Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Stress-induced cigarette craving: Effects of the DRD2 Taql RFLP and SLC6A3 VNTR polymorphisms. The Pharmacogenomics Journal, 2004; 4(2):102-109.
Jaroni J, Wright S, Lerman C, Epstein L. Relationship between education and delay discounting in smokers. Addictive Behaviors, 2004; 29(6):1171-1175.
Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome. Psychopharmacology, 2004; 172(3): 271-276.
Lee EM, Malson JL, Moolchan ET, Pickworth WB. Quantitative comparisons between a nicotine deliver device (Eclipse) and conventional cigarette smoking. Nicotine and Tobacco Research, 2004; 6(1):95-102.
Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine S, Leonard GB, Shields PG, Epstein LH. Changes in food reward following smoking cessation: A pharmacogenetic investigation. Psychopharmacology, 2004; 174(4):571-577.
Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J & Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence. Annals of Internal Medicine, 2004; 140(6): 426-433.
Lerman C, Niaura R, Collins B, Wileyto EP, Audrain-McGovern J, Hawk L, Epstein L. Effects of bupropion on depression symptoms in a smoking cessation clinical trial. Psychology of Addictive Behaviors, 2004; 18(4):362-366.
Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nature Reviews Caner, 2004; 4:235-241.
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini W. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts response to nicotine replacement therapy in a clinical trial. The Pharmacogenomics Journal, 2004; 4(3):184-192.
Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C. Genetics and drug use as a complex phenotype. Substance Use Misuse, 2004; 39(10-12):1515-1569.
Patterson, F., C. Lerman, V. Kaufmann, G.A. Neuner and J. Audrain-McGovern, Cigarette Smoking Practices Among American College Students: Review and Future Directions. Journal of American College Health, 2004; 52(5):203-210.
Perkins K, Lerman C, Kennan J, Fonte C, Coddington S. Rate of nicotine onset from nicotine replacement and acute responses in smokers. Nicotine and Tobacco Research, 2004; 6(3):501-507.
Rodriguez D, Audrain-McGovern J. Team sport participation and smoking: analysis with general growth mixture modeling. Journal of Pediatric Psychology, 2004 Jun; 29(4):299-308.
Rodriguez D & Audrain-McGovern J. Construct validity analysis of the Early Smoking Experience Questionnaire for adolescents. Addictive Behaviors, 2004; 29:1053-1057.
Shields AE, Lerman C, Sullivan P. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine and Tobacco Research, 2004; 6(4):675-688.
Strasser A, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiology Biomarkers and Prevention, 2004; 13(11):1800-1804.
Wileyto EP, Audrain-McGovern J, Epstein LH, Lerman C. Using Logistic Regression to estimate delay-discounting functions. Behavior Research Methods, Instrumentation & Computers, 2004; 36:41-51.
Wileyto EP, Patterson F, Niaura R, Epstein L, Brown R, Audrain-McGovern J, Hawk L, Lerman C. Do small lapses predict relapse to smoking behavior under bupropion treatment. Nicotine and Tobacco Research, 2004; 6:357-368.
2003
Audrain J, Tercyak, KP, Shields A, Bush A, Espinel F, Lerman C. Which adolescents are most receptive to tobacco industry marketing? Implications for counter-advertising campaigns. Health Communication . 2003; 15(4): 499-513.
Audrain-McGovern J, Rodriguez D, Moss HB. Smoking progression and physical activity. Cancer, Epidemiology, Biomarkers & Prevention, 2003; 12: 1121-9.
Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine and Tobacco Research . 2003; 5(S1): S89-99.
Epstein LH, Richards JB, Saad FG, Paluch RA, Roemmich JN, Lerman C. Comparison between two measures of delayed discounting in smokers. Experimental and Clinical Psychopharmacology . 2003; 11(2): 131-8.
Jamner LD, Whalen CK, Loughlin SE, Mermelstein R, Audrain-McGovern J, Krishnan-Sarin S, Worden JK, Leslie FM. Tobacco use across the formative years: A roadmap to developmental vulnerabilities. Nicotine & Tobacco Research, 2003 Dec; 5 Suppl 1:S71-87.
Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: reliability and validity in dependent smokers. Nicotine and Tobacco Research 2003; 5(5):673-9.
Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. American Journal of Medical Genetics (Neuropsychiatric Genetics) . 2003; 118B: 48-54.
Lerman C, Shields PG, Wileyto EP, Audrain J, Hawk L, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein L. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a Bupropion clinical trial. Health Psychology . 2003; 22(5): 541-548.
Malson J, Lee EM, Murty R, Moolchan ET, Pickworth WB. Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacology, Biochemistry & Behavior . 2003; 74(3):739-45.
Miksys S, Lerman C, Shields PG, Mash DC , Tyndale RF. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology . 2003; 45(1): 122-32.
Morgan GD, Kobus K, Gerlach KK, Neighbors C, Lerman C, Abrams DB, Rimer BK. Facilitating Transdiciplinary Research: The experience of the transdisciplinary tobacco use research centers . Nicotine and Tobacco Research . In press.
Patterson F, Benowitz N, Shields PG, Kaufmann V, Jepson C, Wileyto EP, Kucharski S, Lerman C . Individual differences in nicotine intake per cigarette. Cancer, Epidemiology, Biomarkers and Prevention . 2003; 12(3): 468-471.
Patterson F, Benowitz N, Shields PG, Kaufmann V, Jepson C, Wileyto EP, Kucharski S, Lerman C. Individual differences in nicotine intake per cigarette. Cancer, Epidemiology, Biomarkers and Prevention, 2003; 12(3):468-471.
Pickworth WB, O'Hare E, Fant RV, Moolchan ET. EEG effects of conventional and denicotinized cigarettes in a spaced smoking paradigm. Brain and Cognition, 2003 Oct; 53(1):75-81.
Shenassa ED, McCaffery JM, Swan G, Khroyan T, Shakib S, Lerman C, Lyons M, Mouttapa M, Niaura RS, Buka SL, Leslie F, Santangelo SL. Intergenerational transmission of tobacco use and dependence: A transdisciplinary perspective. Nicotine and Tobacco Research. 2003; 5(S1):S55-69.
Steckley, S.L., Pickworth, W.B., Haverkos, H.W. Cigarette smoking and cervical cancer (Part 2): a geographic variability study. Biomedicine Pharmacotherapy 2003; 57:78-83.
Tercyak KP, Audrain-McGovern J. Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Substance Use and Misuse . 2003; 38(14): 1953-1970.
Waters AJ, Sayette M., Wertz J, Carry-over effects can modulate emotional Stroop effects. Cognition and Emotion . 2003: 17(3):501-09.
Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CG, Balabanis MH. Attentional bias predicts outcome in smoking cessation. Health Psychology . 2003; 22(4): 378-387.
Zheng YL, Loffredo CA , Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis . 2003; 24(2):269-74. Erratum in: Carcinogenesis. 2003;24(8):1425.
2002
Audrain J, Tercyak KP, Goldman P, Bush A. Recruiting adolescents into genetic studies of smoking behavior. Cancer Epidemiology Biomarkers & Prevention. 2002; 11(3):249-52.Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, Hawk L, Wileyto P, Shields PG, Lerman C. Dopamine transporter genotype as a risk factor for obesity in smokers. Obesity Research. 2002; 10(12) 1232-1240.
Hemminki K, Shields PG. Skilled use of DNA polymorphisms as a tool for polygenic cancers. Carcinogenesis. 2002; 23(3):379-380.
Lerman C, Croyle RT, Tercayk KP, Hamann H. Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology. 2002; 70(3); 784-97.
Lerman C, Niaura R. Applying genetic approaches to the treatment of nicotine dependence. Oncogene. 2002; 21(48):7412-20.
Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of Bupropion in smoking cessation treatment. Drug and Alcohol Dependence. 2002; 67(2): 219-223.
Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics. 2002; 12(8): 627-634.
Lerman C, Swan G. Non-replication of genetic association studies: is DAT all, folks?
Nicotine and Tobacco Research. 2002; 4(3):247-9.
Malson J, Lee EM, Moolchan ET, Pickworth WB. Nicotine delivery from smoking bidis and a non-additive cigarette. Nicotine and Tobacco Research. 2002; 4(4):485-490.
Malson JL, Pickworth WB. Bidis-hand-rolled, Indian cigarettes: Effects on physiological, biochemical and subjective measures. Pharmacology, Biochemistry, & Behavior. 2002 May; 72(1-2): 443-7.
Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002; 21(45): 6870-6.
Shields PG. Tobacco smoking, harm reduction, and biomarkers. Journal of the National Cancer Institute. 2002; 94(19): 1435-44.
Tercyak KP, Audrain J. Psychosocial correlates of alternative tobacco product use in early adolescence. Preventive Medicine. 2002; 35: 193-8.
Tercyak KP, Goldman P, Smith A, Audrain J. Interacting effects of depression and tobacco advertising receptivity on adolescent smoking. Journal of Pediatric Psychology. 2002; 27(2):145-54.
Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 2002; 41(7):799-805.
Wilfond BS, Geller G, Lerman C, Audrain-McGovern J, Shields AE. Ethical issues in conducting behavioral genetics research: The case of smoking prevention trials among adolescents . Journal of Health Care Law & Policy . 2002; 6(1):73-88.
2001
Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ, Utermahlan B, Falk RT, Shields P. Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiology Biomarkers & Prevention. 2001; 10:261-3.
Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine and Tobacco Research. 2001; 3:353-9.
Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D, Shields PG. Tryptophan hydroxylase gene variant and smoking behavior. American Journal of Medical Genetics (Neuropsychiatric Genetics). 2001;105:518-20.
Malson JL, Sims K, Murty R, Pickworth WB. Comparison of the nicotine content of tobacco used in bidis and conventional cigarettes. Tobacco Control. 2001; 10:181-3. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ. 2001; 322:1056-9.
Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ. 2001; 322:1056-9.
2000
Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry. 2000; 5(2):189-92.